<code id='48D2511C4D'></code><style id='48D2511C4D'></style>
    • <acronym id='48D2511C4D'></acronym>
      <center id='48D2511C4D'><center id='48D2511C4D'><tfoot id='48D2511C4D'></tfoot></center><abbr id='48D2511C4D'><dir id='48D2511C4D'><tfoot id='48D2511C4D'></tfoot><noframes id='48D2511C4D'>

    • <optgroup id='48D2511C4D'><strike id='48D2511C4D'><sup id='48D2511C4D'></sup></strike><code id='48D2511C4D'></code></optgroup>
        1. <b id='48D2511C4D'><label id='48D2511C4D'><select id='48D2511C4D'><dt id='48D2511C4D'><span id='48D2511C4D'></span></dt></select></label></b><u id='48D2511C4D'></u>
          <i id='48D2511C4D'><strike id='48D2511C4D'><tt id='48D2511C4D'><pre id='48D2511C4D'></pre></tt></strike></i>

          fashion

          fashion

          author:focus    Page View:72119
          health care AI border between health care and tech
          Adobe

          There’s been significant investment in companies creating artificial intelligence (AI) applications for health and health care over the last decade. But while there have been successes, notably in the area of medical imaging, the industry is known more for not yet living up to its potential — think IBM Watson.

          The slow pace of AI adoption in health care stems from the fact that health AI sits on the border between two large industries, health care and tech. And like the border between two nations, there are significant differences on either side.

          advertisement

          During my career, I have spent time on each side. Now, as the CEO of a company on the border, I’ve developed a deeper understanding of the differences that create barriers to mutual innovation. For health AI to achieve its potential, health care and tech companies must keep the big picture top of mind: health care is about saving lives.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          FDA approval of Sarepta Duchenne genetic therapy gives me hope
          FDA approval of Sarepta Duchenne genetic therapy gives me hope

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

          read more
          Novo Holdings to buy drug manufacturer Catalent in $16.5B deal
          Novo Holdings to buy drug manufacturer Catalent in $16.5B deal

          CarstenSnejbjerg/BloombergLONDON—TheinvestmentarmofNovoNordisk’sparentfoundationisbuyingdrugmanufact

          read more
          United colonoscopy coverage change 'may cost lives,' doctors say
          United colonoscopy coverage change 'may cost lives,' doctors say

          AdobeWhengastroenterologistslearnedinMarchthatUnitedHealthcareplanstobarricademanycolonoscopiesbehin

          read more

          A single Democrat is willing to weaken Medicare negotiation power

          U.S.RepresentativeDonDavis(D-N.C.)WikimediaCommonsWASHINGTON—TwoRepublicanlawmakerswhointroducedlegi